Polymarket says Roche begins building autonomous AI labs for drug discovery
Polymarket says pharmaceutical company Roche has begun building autonomous AI labs designed to accelerate drug discovery and development.
The report does not specify where the labs will be built, when they are expected to operate, or which discovery or development steps they will cover.